Rethinking addiction in the age of Ozempic
GLP-1 drugs like Ozempic, originally developed for diabetes and weight loss, are showing unexpected promise in treating addiction by modulating the brain’s reward system, offering a potential shift in how we understand and treat substance use disorders. Yet experts caution against viewing
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Dhruv Khullar
narrative on TED Radio Hour
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Research & Papers
Topics
Listen to This Episode
More from TED Radio Hour
Tracking what your body needs
Are we using screens as a scapegoat for teen mental health?
How to feel alive in an exhausting world
The case for merging human bodies with machines
How to mend a broken heart
Could AI help us, not replace us?
Related episodes
From other shows on similar topics.
Dopamine Expert: Short Form Videos Are Frying Your Brain! This Is A Dopamine Disaster!
The Diary Of A CEO with Steven Bartlett
People are running their own experiments with GLP-1s — with stunning results
Apple News Today
Ibogaine: A Miracle Psychedelic?
Science Vs
What we got wrong about GLP-1s
Search Engine
Reshaping the GLP-1 Economy: A Breaking Consumer Study
We Fixed It, You're Welcome
Skinny and sad on GLP-1s
Today, Explained
Get summaries like this every morning.
Free AI-powered recaps of TED Radio Hour and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.